The stakes could hardly be higher. Global agriculture must deliver substantial yield gains by 2050 to feed a growing population while sharply reducing its environmental footprint. Today, pests and pathogens destroy between 20 and 40 percent of annual crop production, losses that are overwhelmingly managed with chemical pesticides carrying well-documented ecological and human health costs, from pollinator decline to contaminated waterways and rising greenhouse gas emissions associated with pesticide manufacture and application. RNA interference offers a fundamentally different approach: a mechanism that can be tuned with near-surgical precision to attack a single pest species while leaving beneficial insects, plants, and mammals untouched.

The underlying biology is elegant. RNAi is a natural gene-silencing pathway found across eukaryotes, first characterized by Andrew Fire and Craig Mello in the nematode Caenorhabditis elegans, work that earned the 2006 Nobel Prize in Physiology or Medicine. When a cell encounters double-stranded RNA, or dsRNA, an enzyme called Dicer slices it into small interfering RNAs. These fragments are loaded into the Argonaute-containing RNA-induced silencing complex, which uses one strand as a guide to find and degrade complementary messenger RNAs. If the dsRNA is designed to match a gene that is essential to a pest’s survival, ingesting it can shut down that gene and kill or debilitate the organism. Because the guide sequence can be chosen to match a target found only in the pest, the specificity of the approach far exceeds that of broad-spectrum chemical insecticides.

Two delivery strategies dominate the field. Host-induced gene silencing, or HIGS, builds the silencing construct directly into the crop’s genome, so the plant itself continuously produces dsRNA aimed at its attackers. Spray-induced gene silencing, or SIGS, instead applies dsRNA externally as a foliar spray, much like a conventional pesticide but with a biological active ingredient. HIGS delivered the first commercial success: the trait MON 87411, targeting western corn rootworm, was introduced in 2022 as part of SmartStax PRO maize, followed by additional RNAi-enabled products such as Bayer’s VT4PRO. SIGS reached the market more recently, when Calantha, developed by GreenLight Biosciences, became in 2023 the first foliar-applied RNA-based biopesticide registered by the United States Environmental Protection Agency, targeting the Colorado potato beetle.

Under controlled laboratory conditions, RNAi can achieve efficacy above 90 percent against susceptible target pests, a figure that rivals or exceeds many conventional insecticides. Yet responsiveness varies dramatically across taxa. Coleopteran insects such as beetles tend to be highly sensitive, while lepidopterans, the moths and butterflies that include some of the world’s most destructive caterpillar pests, often show weak or inconsistent responses. Research has traced this variability to several factors: differences in dsRNA uptake mechanisms, the activity of dsRNA-degrading nucleases in the gut and hemolymph, the efficiency of the core silencing machinery itself, and even the pH and enzymatic environment of the digestive tract. Some insects have also evolved outright resistance, as demonstrated in laboratory-selected populations of western corn rootworm and Colorado potato beetle, a reminder that any pest control technology must be deployed within a resistance management framework.

The second major barrier is environmental persistence. Naked dsRNA is fragile. It degrades rapidly in soil, on leaf surfaces, and in water, attacked by ubiquitous ribonucleases, ultraviolet radiation, and microbial activity. Studies of environmental fate have shown that dsRNA applied to soils typically dissipates within days, which is reassuring from an ecological risk perspective but problematic for growers who need a product to remain active long enough to protect the crop. This instability drives up the dose and frequency of application, and with it the cost, since dsRNA remains considerably more expensive to manufacture than conventional agrochemicals.

Formulation science is racing to close that gap. Nanoparticle carriers, including layered double hydroxide clay nanosheets, chitosan particles, lipid nanoparticles, carbon quantum dots, and engineered nanovesicles, can shield dsRNA from degradation and, in some systems, release it gradually over days or weeks. The BioClay platform, for example, has demonstrated prolonged protection against plant viruses and fungal pathogens by anchoring dsRNA on clay nanosheets that slowly desorb the payload. pH-responsive nanoparticles that release dsRNA in the alkaline midgut of target insects, cell-penetrating peptides that ferry RNA across membranes, and chemically modified dsRNAs that resist nuclease attack are all under active development. Meanwhile, microbial delivery systems are emerging as a complementary route: engineered bacteria and fungi can produce dsRNA in situ, and symbiotic microbes have been used to deliver silencing constructs to mosquito larvae and other targets.

Cost, too, is falling. Traditional dsRNA production relied on in vitro transcription, which is expensive at agricultural scale. Bacterial fermentation using strains optimized for dsRNA accumulation, cell-free production systems, and engineered microbes such as Corynebacterium glutamicum equipped with phage expression machinery have all been shown to yield long dsRNAs suitable for pest control at a fraction of the cost. Computational tools for dsRNA design, including multi-target chimeric designers and off-target prediction software, are simultaneously improving the precision and safety of candidate molecules by screening against the genomes of non-target organisms such as pollinators and natural enemies.

The third barrier is regulatory, and it may be the most consequential. Because RNAi products straddle the boundary between biotechnology and crop protection, jurisdictions classify them inconsistently: as biochemical pesticides, as plant-incorporated protectants, or as novel active substances requiring full GMO-style assessment. The United States has moved fastest, registering both transgenic RNAi traits and sprayable dsRNA products, while the European Union and many other regions are still defining their frameworks. This patchwork creates uncertainty for developers, delays market entry, and risks leaving growers in some regions without access to tools approved elsewhere. Review authors and other commentators have called for global regulatory cohesion, arguing that harmonized, science-based risk assessment frameworks are essential if RNAi biopesticides are to contribute meaningfully to sustainable food production and to the United Nations Sustainable Development Goals.

None of these challenges diminishes the underlying promise. RNAi aligns with the central demands of twenty-first-century agriculture: high specificity, low residues, minimal impact on non-target organisms, and compatibility with integrated pest management. The technology extends beyond pest killing, with demonstrated applications in improving shelf life, enhancing abiotic stress tolerance, modifying oil composition, and managing fungal, viral, and nematode pathogens. What the new review makes clear is that the remaining obstacles are engineering and governance problems rather than fundamental biological ones. If nanoparticle formulations, cheap microbial production, and coherent regulation mature together, RNA interference could indeed become a cornerstone of next-generation agriculture, turning a Nobel-winning discovery into the everyday toolkit of the sustainable farm.

Subject of Research: RNA interference as a sustainable crop protection technology and the barriers to its field deployment

Article Title: RNAi: the next wave of green agriculture, challenges, and bridging the translational gap

Article References: Abdullah, Z. K., Kong, L. L., Ariffin, N., & Wong, M. Y. (2026). RNAi: the next wave of green agriculture, challenges, and bridging the translational gap. Plant Cell Reports, 45(9), Article 271. https://doi.org/10.1007/s00299-026-03939-x

Image Credits: AI Generated

DOI: 10.1007/s00299-026-03939-x

Keywords: RNA interference, RNAi biopesticides, double-stranded RNA, spray-induced gene silencing, host-induced gene silencing, crop protection, sustainable agriculture, nanoparticle delivery, dsRNA stability, pest control, regulation, Plant Cell Reports

The underlying biology is elegant. RNA interference is a natural cellular defense pathway in which double-stranded RNA molecules are cut into small interfering RNAs that guide protein complexes to complementary messenger RNAs, triggering their degradation. When a double-stranded RNA molecule is designed to match a gene that is essential for a pest’s survival, feeding or topically applying that molecule can selectively shut down the target gene and kill or debilitate the pest without touching the crop itself. Because the sequence match must be precise, the approach offers a degree of specificity that broad-spectrum synthetic chemicals rarely achieve. The machinery is ancient and widespread: Dicer enzymes and Argonaute proteins, the core components of the silencing pathway, operate in insects, mites, nematodes, fungi and plants, which is precisely why the technology can in principle be aimed at such a diverse roster of agricultural enemies.

The scientific foundations were laid decades before anyone thought of spraying RNA on a field. Observations of virus-induced ring spot disease in the 1920s, co-suppression of genes in petunias in 1990 and quelling in Neurospora in 1992 all hinted at homology-dependent gene silencing. Andrew Fire and Craig Mello’s 1998 demonstration of potent and specific interference by double-stranded RNA in Caenorhabditis elegans unified these threads, and subsequent work identified Dicer as the enzyme that dices long double-stranded RNA and Argonaute2 as the catalytic engine of silencing. By 2007, researchers had shown that RNA interference could control coleopteran pests and that plant-mediated silencing could disable cotton bollworm detoxification genes. Cross-kingdom RNAi, in which fungal small RNAs hijack host plant machinery and plants dispatch small RNAs in extracellular vesicles to silence fungal virulence genes, revealed that this molecular arms race was already running between crops and their pathogens.

Two commercial milestones now anchor the field. A sprayable double-stranded RNA product targeting the proteasome subunit beta type-5 gene of the Colorado potato beetle, marketed as Calantha, became the first RNAi-based biopesticide registered for field use, with the US Environmental Protection Agency approving its product label in late 2023. More recently, a product called Norroa has been evaluated against Varroa destructor, the parasitic mite that devastates managed honey bee colonies worldwide. Laboratory and field trials have demonstrated toxicity of the dsRNA-based insecticide to the beetle, and studies of Norroa in managed hives suggest suppression of mite reproduction. These registrations matter because they demonstrate that regulators in at least one major jurisdiction are willing to assess and approve nucleic-acid-based crop protection products, opening a pathway that competitors can follow.

Yet the review’s authors are careful to frame adoption as an economic and social decision, not merely a technical one. They model farmer uptake as a return-on-investment calculation shaped by three levers: agricultural utility, meaning safe and reliable efficacy against pests and pathogens; regulatory reality, meaning the barriers that determine whether products actually reach the market; and social licence, meaning public perception and acceptance of a novel biotechnology. The backdrop makes the calculus favorable in principle. Pests and pathogens impose a staggering global burden on major food crops, pesticide use continues to climb, resistance to conventional chemistries is spreading through both established and newly emerging mechanisms, and regulatory restrictions are steadily withdrawing older synthetic actives from the market. Every withdrawn chemistry leaves a gap that RNAi-based products could fill, provided the cost-benefit ratio tips in their favor.

Delivering double-stranded RNA intact to the right cells remains the central technical challenge, and it is one where recent progress has been dramatic. RNA is notoriously fragile: nucleases in insect guts and on leaf surfaces degrade it rapidly, and some bacteria associated with plants actively secrete nucleases that chew up dsRNA before it can act. Different pests vary enormously in their sensitivity, with beetles generally responding well while many lepidopterans and aphids show weak responses linked to endosomal entrapment and rapid degradation. Nanotechnology offers a way through. Layered clay nanosheets known as BioClay have been shown to release RNA slowly on leaf surfaces for sustained protection against plant viruses, while liposome encapsulation, chitosan nanoparticles, graphene quantum dots and artificial membrane-chimeric nanovesicles have each improved delivery and efficacy in systems ranging from stink bugs to Fusarium head blight in wheat. Recent work even shows that foliar-applied double-stranded RNA is mobile within the plant and can transfer to pathogens to trigger silencing.

Designing the RNA sequence itself has become a computational science. A growing suite of bioinformatics tools now screens candidate double-stranded RNAs for efficacy and safety simultaneously. Platforms such as dsRIP, dsRNAEngineer, SIREN and dsRNAmax help researchers select target genes, design chimeric multi-target constructs and predict off-target complementarity against non-target organisms. This matters because off-target silencing correlates with the mismatch rate between the dsRNA and non-target messenger RNAs, so a well-designed 21-24 nucleotide stretch of sequence identity can be the difference between a selective product and an ecological liability. Computational risk assessment frameworks, including ecological and human health frameworks developed specifically for externally applied dsRNA biopesticides, formalize this screening into a pipeline that regulators can evaluate, and OECD consensus documents now outline considerations for both human health and environmental risk assessment of sprayed dsRNA products.

Environmental fate data have been reassuring so far. Studies of double-stranded RNA in agricultural soils and in sediment-water systems following over-water application show rapid degradation, consistent with the expectation that RNA does not persist in the environment the way persistent organic pollutants do. Vertebrate safety evaluations, including 28-day oral toxicity studies of small interfering RNAs and long dsRNA in mice, have found no adverse effects at relevant exposures, and computational analyses of crop transcriptomes help quantify any residual sequence complementarity with human genes. Resistance is the thornier long-term question. Researchers have deliberately selected dsRNA-resistant populations of Colorado potato beetle and western corn rootworm, demonstrating that resistance can evolve, although notably, dsRNA-resistant beetle larvae remained fully susceptible to small-molecule pesticides, suggesting RNAi and conventional chemistries could rotate as complementary modes of action rather than compete.

The most uncertain variable may be the least technical: social licence. A systematic review of public perceptions of RNAi-based biopesticides highlights that acceptance will hinge on how the technology is communicated, particularly around questions of safety, residues on food, and the simple fact that spraying a gene-silencing molecule sounds like genetic modification to many consumers, even though no organism’s genome is altered. Lessons from nanotechnology risk governance and from the fraught history of transgenic crops suggest that early, transparent engagement with the public and with ethical, legal and social discourses is essential. The authors also flag fragmented international regulatory harmonization as a brake on adoption: without global cohesion on how dsRNA products are assessed, developers face a patchwork of requirements that raises costs and delays market entry, particularly for smaller companies and for products aimed at minor crops.

What emerges from the review is a technology at an inflection point. The molecular machinery is understood, the delivery systems are maturing, the design tools are automated, the risk assessment frameworks are published, and two registered products have proven that the regulatory pathway exists. The remaining work is to make the economics work at scale, to align regulators across borders, and to earn the public trust that any agricultural biotechnology ultimately requires. If those levers move in the right direction, RNAi-based biopesticides could become a cornerstone of sustainable pest management, filling the market gaps left by withdrawn chemistries with a weapon that is as precise as a sequence and as biodegradable as the RNA it deploys.

Subject of Research: Adoption of RNA interference-based biopesticides for agricultural pest and pathogen control

Article Title: Advancing the adoption of RNA interference-based biopesticides

Article References: Fletcher, S., Gunasekara, S., Narva, K., De Neef, E., Ashworth, P., Jin, H., & Mitter, N. (2026). Advancing the adoption of RNA interference-based biopesticides. Nature Plants. https://doi.org/10.1038/s41477-026-02409-2

Image Credits: AI Generated

DOI: 10.1038/s41477-026-02409-2

Keywords: RNA interference, biopesticides, double-stranded RNA, crop protection, Colorado potato beetle, varroa mite, gene silencing, nanocarriers, pesticide resistance, regulatory harmonization, social licence, integrated pest management